Taylor comes to the North Billerica, MA-based firm after serving as vice president of regulatory affairs for both Tolerx and CuraGen. She has more than 25 years of experience in the pharmaceutical regulatory industry, Lantheus said.
Related Reading
Study: Echo with Definity contrast aids in cardiac diagnosis, February 24, 2009
SPECT MPI works for CAD, Lantheus says, January 27, 2009
Lantheus touts positive Definity results, December 16, 2008
Lantheus scores Premier contract, October 24, 2008
Lantheus to license Bracco's CardioGen PET tracer, September 24, 2008
Copyright © 2009 AuntMinnie.com
